Patrys Limited Is An Australian Biotechnology Company Based In Melbournefocused On Developing Innovative Antibody Based Therapies For Cancer And Inflammatory Diseases Driven By Netosisestablished In 2006The Company Is Publicly Listed On The Australian Securities Exchange Under The Ticker Pab The Core Technology Of Patrys Is The Deoxymab Platformwhich Includes Antibodies Designed To Penetrate Cell Nuclei And Target Dna Repair Mechanismsnotable Products Include Pat Dx1Aimed At Treating Brain Cancers And Metastasesand Pat Dx3A Full Sized Antibody Variant That Improves Tissue Distributionthe Company Is Dedicated To Enhancing The Effectiveness Of Radiation And Chemotherapy In Oncology And Addressing Conditions Related To Netosis Through Targeted Therapieswith A Small Team Of 11 50 Employeespatrys Is Led By Ceo Drjames Acampbell And Is Committed To Advancing Its Research In Blood Brain Barrier Penetration And Dna Targeting Mechanisms
No conferences found for this company.
| Company Name | Patrys Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
